(Q48713671)

English

The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: Effects on peripheral sensory nerve function, structure and molecular changes.

scientific article published on 25 November 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26603140

The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: Effects on peripheral sensory nerve function, structure and molecular changes. (English)

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26603140

author name string

Kentaro Tsuboi

1

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26603140

Hiroki Mizukami

2

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26603140

Wataru Inaba

3

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26603140

Masayuki Baba

4

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26603140

Soroku Yagihashi

5

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26603140

language of work or name

0 references

publication date

25 November 2015

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26603140

Journal of Neurochemistry

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26603140

Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Alpha-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Direct insulin signaling of neurons reverses diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Insulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Peripheral nervous system insulin resistance in ob/ob mice.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

In vivo peripheral nervous system insulin signaling

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

The nonglycemic actions of dipeptidyl peptidase-4 inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

The effects of dipeptidyl-peptidase-IV inhibitor, vildagliptin, on the exocrine pancreas in spontaneously diabetic Goto-Kakizaki rats.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Calcium/calmodulin-dependent kinase IV controls glucose-induced Irs2 expression in mouse beta cells via activation of cAMP response element-binding protein.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Effects of polyol pathway hyperactivity on protein kinase C activity, nociceptive peptide expression, and neuronal structure in dorsal root ganglia in diabetic mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Neuroprotective actions of glucagon-like peptide-1 in differentiated human neuroprogenitor cells.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Hyperlipidemia: a new therapeutic target for diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Effects of long-term treatment with alpha-glucosidase inhibitor on the peripheral nerve function and structure in Goto-Kakizaki rats: a genetic model for type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Beneficial Effects of PKF275-055, a Novel, Selective, Orally Bioavailable, Long-Acting Dipeptidyl Peptidase IV Inhibitor in Streptozotocin-Induced Diabetic Peripheral Neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13439

21 January 2018

Identifiers

10.1111/JNC.13439

0 references

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/26603140

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48713671&oldid=2143811063"